Rigel's fostamatinib enters Phase 1 trial for sickle cell treatment
This article is based on a press release statement from Rigel Pharmaceuticals (NASDAQ:RIGL), Inc. The company maintains a healthy financial position with a current ratio of 1.96 and operates with a ...
M87* observations catch the black hole's turbulent accretion flow
Using observations from 2017 and 2018, the Event Horizon Telescope (EHT) Collaboration has advanced our understanding of the ...
sicklecellanemianews1d
Clinical trial data on pociredir as SCD therapy expected by midyear
New data from a Phase 1b clinical trial testing Fulcrum's pociredir for sickle cell disease are expected by the middle and ...
Tuesdays with Toomey1d
Disruptors Alexis A. Thompson and Stephan A. Grupp
CHOP doctors Thompson and Grupp have devoted their lives to improving the quality and length of life for children with sickle ...
Controlling plasma heat in a fusion energy power plant: 'Louvers' on fusion device should exhaust gases as hot as a star
Commonwealth Fusion Systems (CFS) is developing a tokamak device called SPARC. The company aims to demonstrate the critical ...
The Punch Newspapers5d
Sickle cell and eye problems
While much attention is given to the painful crises, anaemia, and organ damage caused by SCD, its impact on vision is equally ...
The Week6d
FACT CHECK: Is hypertrophic cardiomyopathy the leading cause of sudden deaths in young gym-goers?
While a viral Instagram reel links sudden gym deaths to a genetic heart condition, find out what experts say and why more ...